West Pharmaceutical Services Net Change in Short-term Investments 2010-2025 | WST

West Pharmaceutical Services annual/quarterly net change in short-term investments history and growth rate from 2010 to 2025. Net change in short-term investments can be defined as the net cash flows from the sale and purchase of investments defined to be short-term, generally with maturities of less than one year from the purchase date.
  • West Pharmaceutical Services net change in short-term investments for the quarter ending March 31, 2025 was $0M, a 0% increase year-over-year.
  • West Pharmaceutical Services net change in short-term investments for the twelve months ending March 31, 2025 was $0M, a 0% increase year-over-year.
  • West Pharmaceutical Services annual net change in short-term investments for 2024 was $0B, a 0% decline from 2023.
  • West Pharmaceutical Services annual net change in short-term investments for 2023 was $0B, a 0% decline from 2022.
  • West Pharmaceutical Services annual net change in short-term investments for 2022 was $0B, a 0% decline from 2021.
West Pharmaceutical Services Annual Net Change in Short-term Investments
(Millions of US $)
2024 $N/A
2023 $N/A
2022 $N/A
2021 $N/A
2020 $N/A
2019 $N/A
2018 $N/A
2017 $N/A
2016 $N/A
2015 $N/A
2014 $8
2013 $5
2012 $14
2011 $-26
2010 $N/A
2009 $N/A
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $15.606B $2.893B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $90.882B 21.95
Becton Dickinson (BDX) United States $50.744B 12.57
Cardinal Health (CAH) United States $36.723B 19.23
Straumann Holding AG (SAUHY) Switzerland $21.343B 0.00
Labcorp (LH) United States $20.908B 16.96
Cooper (COO) United States $16.380B 21.73
Align Technology (ALGN) United States $13.398B 26.60
Henry Schein (HSIC) United States $8.744B 15.00
Merit Medical Systems (MMSI) United States $5.798B 28.03
DENTSPLY SIRONA (XRAY) United States $3.314B 9.90
CONMED (CNMD) United States $1.865B 13.95
STAAR Surgical (STAA) United States $0.953B 0.00
Lifevantage (LFVN) United States $0.166B 17.12
Pro-Dex (PDEX) United States $0.141B 15.44